Specific inhibition of GM1 synthesis by targeting B4GALNT1 or inhibition of the interaction between GM1 and IR could be employed to develop new efficient therapeutic strategies for vascular insulin resistance (Figure 3C). Here, B4GALNT1 is linked to Insulin resistance.